FDA Adverse Event Injury Summary report: N

VENTAK PRIZM 2

MDR report key: 2911461 · Received January 11, 2013

Report

Report Number
2124215-2012-16021
Event Type
Injury
Date Received
January 11, 2013
Date of Event
November 26, 2012
Report Date
January 16, 2013
Manufacturer
GUIDANT CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE DEVICE WAS THOROUGHLY INSPECTED AND ANALYZED. THE DEVICE WAS THEN SUBJECTED TO A SERIES OF AUTOMATED DIAGNOSTIC TESTS THAT VERIFY THE PERFORMANCE OF THE DEFIBRILLATION, PACING, SENSING, HIGH VOLTAGE SHOCKING AND RECORDING FUNCTIONS OF THE DEVICE. THE DEVICE PERFORMED NORMALLY THROUGHOUT ALL TESTS.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THIS DEVICE WAS EXPLANTED DUE TO NORMAL BATTERY DEPLETION. NO ADVERSE PATIENT EFFECTS WERE REPORTED DURING THE PROCEDURE. THE DEVICE WAS RETURNED TO ALLOW FOR RELIABILITY ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS DEVICE WAS LOST TO FOLLOW UP, AS THE PATIENT WAS DNR AND DID NOT WANT A DEVICE REPLACEMENT. THE PATIENT WAS PRESENTED TO THE ER WITH A SYNCOPAL EVENT OF AN UNKNOWN LENGTH OF TIME. UPON RECENT DEVICE INTERROGATION, THE DEVICE WAS AT END OF LIFE (EOL) WITH A BATTERY VOLTAGE OF 1.92 V. THRESHOLD MEASUREMENTS WERE WITHIN ACCEPTABLE LIMITS. THE PATIENT WAS REPORTEDLY DOING FINE, RELEASED FROM THE ER AND WAS TO FOLLOW UP WITH THE CARDIOLOGIST.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
18564 VENTAK PRIZM 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CLONMEL IRELAND 1860

Patients

Seq Age Sex Outcome Treatment
1 95 YR Hospitalization| L 1860| 1762| 0125